Abiopharma

News list

Director PRINS RICHARD K 🟢 acquired 750.0K shares (1 derivative) of IGC Pharma, Inc. (IGC) Transaction Date: Oct 17, 2025 | Filing ID: 001520

Full text

News bot Oct. 22, 2025, 12:30 p.m.
🔍 PRINS RICHARD K (Director)

Company: IGC Pharma, Inc. (IGC)

Report Date: 2025-10-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 750,000
Detailed Transactions and Holdings:
- Acquired 750,000 shares of Options (Derivative)
  Date: 2025-10-17 | Code: A | Expires: 2038-03-31 | equity_swap_involved: 0 | shares_owned_after: 750,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
Footnotes:
- F1: The Reporting Person was granted 750,000 options exercisable at $0.35, equally vesting over the next three years starting on March 31st, 2026.